Who Paid My Doc
Research study
Program year 2024
Source: CMS Open Payments
Lorlatinib Clinical Publication Program
Research payments
$84,470
Through program year 2024, $84,470 in research payments was reported against Lorlatinib Clinical Publication Program, across 93 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $13,470 | 26 |
| 2023 | Research | $3,300 | 10 |
| 2022 | Research | $3,200 | 1 |
| 2021 | Research | $30,670 | 26 |
| 2020 | Research | $33,830 | 30 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.